My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Role for VPAC2 receptor-mediated signals in pancreas development.

    Rachdi L, Marie JC, Scharfmann R.

    Diabetes. 2003 Jan;52(1):85-92.PMID: 12502497 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.

    Akesson L, Ahrén B, Edgren G, Degerman E.

    Endocrinology. 2005 Feb;146(2):744-50. Epub 2004 Oct 28.PMID: 15514088 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cytosolic Ca2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors.

    Yamada H, Watanabe M, Yada T.

    Regul Pept. 2004 Dec 15;123(1-3):147-53.PMID: 15518905 [PubMed - indexed for MEDLINE]Related articles

    4.

    Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide attenuate the cigarette smoke extract-induced apoptotic death of rat alveolar L2 cells.

    Onoue S, Ohmori Y, Endo K, Yamada S, Kimura R, Yajima T.

    Eur J Biochem. 2004 May;271(9):1757-67.PMID: 15096214 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.

    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.

    Oncol Rep. 2005 Jun;13(6):1217-21.PMID: 15870945 [PubMed - indexed for MEDLINE]Related articles

    6.

    Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.

    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.

    J Endocrinol. 2006 Oct;191(1):287-99.PMID: 17065411 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors.

    Nicol MR, Cobb VJ, Williams BC, Morley SD, Walker SW, Mason JI.

    J Mol Endocrinol. 2004 Jun;32(3):869-77.PMID: 15171718 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.

    Juarranz MG, Bodega G, Prieto JC, Guijarro LG.

    Prostate. 2001 Jun 1;47(4):285-92.PMID: 11398176 [PubMed - indexed for MEDLINE]Related articles

    9.

    Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.

    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.

    Reproduction. 2007 Aug;134(2):281-92.PMID: 17660238 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells.

    Cazillis M, Gonzalez BJ, Billardon C, Lombet A, Fraichard A, Samarut J, Gressens P, Vaudry H, Rostène W.

    Eur J Neurosci. 2004 Feb;19(4):798-808.PMID: 15009127 [PubMed - indexed for MEDLINE]Related articles

    11.

    Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle.

    Murthy KS, Mahavadi S, Huang J, Zhou H, Sriwai W.

    Am J Physiol Cell Physiol. 2008 Feb;294(2):C477-87. Epub 2007 Dec 12.PMID: 18077607 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.

    Zawilska JB, Niewiadomski P, Nowak JZ.

    Gen Comp Endocrinol. 2004 Jun;137(2):187-95.PMID: 15158130 [PubMed - indexed for MEDLINE]Related articles

    13.

    Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide.

    Yung SL, Dela Cruz F, Hamren S, Zhu J, Tsutsumi M, Bloom JW, Caudle M, Roczniak S, Todd T, Lemoine L, MacDougall M, Shanafelt AB, Pan CQ.

    J Biol Chem. 2003 Mar 21;278(12):10273-81. Epub 2003 Jan 13.PMID: 12525492 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.

    Delgado M, Reduta A, Sharma V, Ganea D.

    J Leukoc Biol. 2004 Jun;75(6):1122-30. Epub 2004 Mar 12.PMID: 15020654 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.

    Fizanne L, Sigaudo-Roussel D, Saumet JL, Fromy B.

    J Physiol. 2004 Jan 15;554(Pt 2):519-28. Epub 2003 Oct 24.PMID: 14578481 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.

    Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T.

    J Neuroimmunol. 2005 Jan;158(1-2):94-105.PMID: 15589042 [PubMed - indexed for MEDLINE]Related articles

    17.

    VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.

    Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jégou S, Janet T, Gressens P.

    J Pharmacol Exp Ther. 2005 Aug;314(2):745-52. Epub 2005 May 4.PMID: 15872042 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.

    Hayez N, Harfi I, Lema-Kisoka R, Svoboda M, Corazza F, Sariban E.

    J Neuroimmunol. 2004 Apr;149(1-2):167-81.PMID: 15020077 [PubMed - indexed for MEDLINE]Related articles

    19.

    Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.

    Zawilska JB, Niewiadomski P, Nowak JZ.

    Pol J Pharmacol. 2004 Mar-Apr;56(2):203-11.PMID: 15156071 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei.

    Harmar AJ.

    J Neuroendocrinol. 2003 Apr;15(4):335-8. Review.PMID: 12622830 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity